Team:Paris Bettencourt/Notebook/Drug Screening/Monday 10th June.html
From 2013.igem.org
(2 intermediate revisions not shown) | |||
Line 4: | Line 4: | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Drug_Screen" target="_blank" class="tbnotelogo DSlogo"> ASDF </a> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Drug_Screen" target="_blank" class="tbnotelogo DSlogo"> ASDF </a> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
- | <h3> | + | <h3>Monday 10<sup>th</sup> June</h3> |
<p><b><em> | <p><b><em> | ||
<!-- === Modify from here === --> | <!-- === Modify from here === --> | ||
- | Design of SirA | + | Design of SirA genes for synthesis |
<!-- === To here === --> | <!-- === To here === --> | ||
</br></em></b></p> | </br></em></b></p> | ||
Line 16: | Line 16: | ||
<br>Primers: | <br>Primers: | ||
<br>TBsirA F GGAATTCCATATGTCCGCGAAGGAGAACCCC | <br>TBsirA F GGAATTCCATATGTCCGCGAAGGAGAACCCC | ||
- | <br>TBsirA R AAGGAAAAAAGCGGCCGCTCATCGCAGGTCGTCCTCCTCGGCCCGGAT | + | <br>TBsirA R AAGGAAAAAAGCGGCCGCTCATCGCAGGTCGTCCTCCTCGGCCCGGAT <br> |
We blasted the above primers used to clone sirA from M. tuberculosis into E. coli. We then extracted the sequence from genbank to retrieve the following sequence which includes the restriction sites introduced by Pinto et al.</p> | We blasted the above primers used to clone sirA from M. tuberculosis into E. coli. We then extracted the sequence from genbank to retrieve the following sequence which includes the restriction sites introduced by Pinto et al.</p> | ||
<p style="font-family: courier">ggaattccat atgtccgcga aggagaaccc ccaaatgacc actgcacgtc <br>ccgccaaggc tcgaaatgag | <p style="font-family: courier">ggaattccat atgtccgcga aggagaaccc ccaaatgacc actgcacgtc <br>ccgccaaggc tcgaaatgag | ||
Line 84: | Line 84: | ||
<br>gatttgaggt aggcaacgtg aaagcttggg</p> | <br>gatttgaggt aggcaacgtg aaagcttggg</p> | ||
<p>As above, the sequence was imported into geneious, the biobrick restriction sites were manually removed from the sequence and restriction sites were added to the 5’ and 3’ ends in the same fashion as TB sirA. This resulted in the following sequence for synthesis:</p> | <p>As above, the sequence was imported into geneious, the biobrick restriction sites were manually removed from the sequence and restriction sites were added to the 5’ and 3’ ends in the same fashion as TB sirA. This resulted in the following sequence for synthesis:</p> | ||
- | <p style="font-family: courier"> | + | <p style="font-family: courier"> |
+ | tacagaattc tagaccatgg gcctcgaaga cgagtacttc atgctgcgcg | ||
+ | <br>tgcgctgcga tggtggcgcg ctgaccacta cagcgctgcg cacgctcggc | ||
+ | <br>ggcatctcga ccgagttcgc gcgcgacacc gccgacatct ccgaccgcga | ||
+ | <br>gaacgtccag taccactgga tccaggtcga gaacatgccc gagatctgga | ||
+ | <br>agcgcctcga cgccgtcggc ctacagacca ccgaggcgtg cggcgactgc | ||
+ | <br>ccgcgtgtgg tcctcggctc gccgctggcc ggtgagtccc tcgacgaggt | ||
+ | <br>gatcgacggg acccccgcga tcgacgagat cgtgcgccgc tacatcggca | ||
+ | <br>agcccgagta ctcgaacctg ccgcgcaagt tcaagaccgc gatctcgggg | ||
+ | <br>cttcaggacg tggtccacga ggtcaacgac gtcgcgttca tcggcgtcaa | ||
+ | <br>ccaccccgag cacggcccgg gcttcgacct gtgggtcggt ggcggcctgt | ||
+ | <br>cgaccaaccc gatgctggcc cagcgcgtcg gggtgtgggt gccgctcgac | ||
+ | <br>gaggtgcccg acgtctggga gggcgtcgtc agcatcttcc gcgactacgg | ||
+ | <br>ttaccggcgt ctgcggtcga aggcgcggct gaagttcctg atcaaggact | ||
+ | <br>ggggcgtcga aaagttcagg gaagtgctgg aaaccgagta cctcaagcgc | ||
+ | <br>cccctgatcg acggcccggc acccgaaccg gtgacccgcc ccatcgacca | ||
+ | <br>cgtcggtgtg cagaagctca agaacggcct caacgccgtg ggcgtcgccc | ||
+ | <br>cgatcgcggg tcgcgtctcg ggcacgatcc tgaccaaggt ggccgatctc | ||
+ | <br>gccgaggccg ccgggtccga ccggatccgc ttcacgccgt accagaagct | ||
+ | <br>gatcatcctc gacgtgcccg acgacaagat cgacgaactg cgcgctggcc | ||
+ | <br>tcgacgcgct cggactgccg tcgacgccgt cgcactggcg ccgcaacctc | ||
+ | <br>atggcgtgca cgggtatcga gttctgcaag ctgagcttcg ccgagacccg | ||
+ | <br>caagcgtgcc caggtgctgg ttcccgagct ggagaaacgg ctcgacgaca | ||
+ | <br>tcaacgccca gctcgacgtg cccatcacgg tcaacatcaa cggctgcccc | ||
+ | <br>aactcgtgcg cccgtatcca ggtcgccgac atcgggttca agggccagat | ||
+ | <br>ggtcgacgat ggcaacggcc ccgaggaggg tttccaggtg catctgggcg | ||
+ | <br>gcagcctggg cctggacagc gggttcggcc gcaagctgcg ccagcacaag | ||
+ | <br>gtgctctcgt ccgagctcgg cgactacatc gagcgcgtcg tgcgcaactt | ||
+ | <br>cgtgaaacaa cgcgaggacg gcgagcgttt cgcccagtgg gccgtgcggg | ||
+ | <br>ccgacgaagc ggatttgagg taggcaacgt gaaagcctag gtactagtct | ||
+ | <br>gcagtggg | ||
</p> | </p> | ||
<!-- === To here === --> | <!-- === To here === --> | ||
</div> | </div> | ||
</html> | </html> |
Latest revision as of 09:40, 13 August 2013
Drug Screening
ASDFMonday 10th June
Design of SirA genes for synthesis
SirAMycobacterium tuberculosis
Reference: Pinto et al. 2007. Sulfite Reduction in Mycobacteria doi: 10.1128/JB.00487-07
Primers:
TBsirA F GGAATTCCATATGTCCGCGAAGGAGAACCCC
TBsirA R AAGGAAAAAAGCGGCCGCTCATCGCAGGTCGTCCTCCTCGGCCCGGAT
We blasted the above primers used to clone sirA from M. tuberculosis into E. coli. We then extracted the sequence from genbank to retrieve the following sequence which includes the restriction sites introduced by Pinto et al.
ggaattccat atgtccgcga aggagaaccc ccaaatgacc actgcacgtc
ccgccaaggc tcgaaatgag
ggccagtggg cgctgggaca tcgcgagcca
ctcaacgcca acgaagagct gaagaaggcc
ggcaacccgc tcgacgtgcg
ggagcgcatc gaaaacatct acgccaaaca gggtttcgac
agcatcgaca
agaccgacct gcgagggcgc tttcgctggt ggggcctgta cacccagcgt
gagcagggct acgacggcac ctggaccggt gacgacaaca tcgacaagct
cgaggccaaa
tacttcatga tgcgggtgcg ttgcgacggc ggcgcgctct
cggctgccgc gctgcgcacg
ctgggccaga tctcgacgga gttcgcgcgc
gataccgccg atatctccga ccggcagaac
gtgcaatacc actggatcga
agtggaaaac gtccctgaaa tctggcgacg gttagacgat
gtcggactgc
agaccaccga ggcgtgcggt gactgcccgc gggtagtgct gggctcgccg
ttggccggcg agtcgctcga cgaagtgctc gacccgacct gggcgatcga
ggagatcgtg
cgtcgctaca tcggcaagcc cgacttcgcc gacttgccgc
gcaagtacaa gaccgccatc
tctggcctgc aggacgtcgc gcacgagatc
aacgacgtcg ccttcatcgg cgtcaaccat
cccgagcacg gaccaggcct
ggatctgtgg gtgggcggtg gactgtcgac caacccgatg
ctggcccagc
gggtcggcgc ctgggttcca ctgggcgaag tgcccgaggt gtgggcggcg
gtcacctcgg tgtttcgcga ctacggctac cggcgactgc gcgccaaggc
ccggctgaaa
tttctgatca aagactgggg catagcgaag ttccgcgaag
tgctcgaaac cgagtacctc
aagcgtccgc tgatcgacgg tccggccccc
gaaccggtca agcatccgat cgaccacgtc
ggggtgcaac gactcaagaa
cgggctcaac gccgtcggag tcgcccccat cgccgggcgg
gtatcgggca
ccatcctcac ggcggtcgcc gacctgatgg cgcgggccgg ttccgaccgg
atccggttca ccccctacca gaagctggtc atcctcgaca ttccggacgc
cttgctcgac
gacttgatcg ccggtctgga cgcgctgggg ctgcagtcgc
gcccgtcgca ttggcgccgg
aacttgatgg cgtgcagcgg gattgagttc
tgcaagttgt cattcgccga aacccgggtt
cgagcacagc atttggtgcc
cgagctggaa cgccggcttg aggacatcaa ctcgcagctc
gacgtaccga
tcaccgtcaa catcaacggc tgcccgaact catgtgcgcg aattcaaatc
gccgacatcg gattcaaggg acagatgatc gacgacggac acggcggctc
cgtcgaaggc
ttccaggtgc atctgggcgg acacctcggc ctggatgccg
gattcggccg caaactgcgc
cagcacaagg tcaccagtga cgaactcggc
gactacatcg accgggtggt gcgcaacttc
gtcaaacacc gcagcgaagg
tgaacgcttc gcgcagtggg tcatccgggc cgaggaggac
gacctgcgat
gagcggccgc ttttttcctt
This sequence was then inserted into Geneious. The PstI and EcoRI sites were manually removed and replaced with silent mutations. A NcoI site was inserted at the start codon and an extra glycine was added after the start codon for the NcoI site to function properly. We chose glycine as it is small an unlikely to interfere with either polar or non-polar domains within the protein. We used GGC as the codon as it is the highest used glycine codon in e. coli. We also added an AvrII site on the 3’ end of the site. We then added biobrick restriction sites on the ends of the sequence (EcoRI, XbaI, SpeI, PstI). This will allow us to clone into our expression vector pACYCDuet-1 with NcoI and AvrII enzymes and into a biobrick registry with EcoRI and PstI. The insertion into pACYCDuet-1 removes both protein tags and cuts out the second MCS resulting in vector pACYCDuet-TBsirA. The resulting sequence for TB SirA follows:
catggaattc tagaccatgg gctccgcgaa ggagaacccc caaatgacca
ctgcacgtcc cgccaaggct cgaaatgagg gccagtgggc gctgggacat
cgcgagccac tcaacgccaa cgaagagctg aagaaggccg gcaacccgct
cgacgtgcgg gagcgcatcg aaaacatcta cgccaaacag ggtttcgaca
gcatcgacaa gaccgacctg cgagggcgct ttcgctggtg gggcctgtac
acccagcgtg agcagggcta cgacggcacc tggaccggtg acgacaacat
cgacaagctc gaggccaaat acttcatgat gcgggtgcgt tgcgacggcg
gcgcgctctc ggctgccgcg ctgcgcacgc tgggccagat ctcgacggag
ttcgcgcgcg ataccgccga tatctccgac cggcagaacg tgcaatacca
ctggatcgaa gtggaaaacg tccctgaaat ctggcgacgg ttagacgatg
tcggacttca gaccaccgag gcgtgcggtg actgcccgcg ggtagtgctg
ggctcgccgt tggccggcga gtcgctcgac gaagtgctcg acccgacctg
ggcgatcgag gagatcgtgc gtcgctacat cggcaagccc gacttcgccg
acttgccgcg caagtacaag accgccatct ctggccttca ggacgtcgcg
cacgagatca acgacgtcgc cttcatcggc gtcaaccatc ccgagcacgg
accaggcctg gatctgtggg tgggcggtgg actgtcgacc aacccgatgc
tggcccagcg ggtcggcgcc tgggttccac tgggcgaagt gcccgaggtg
tgggcggcgg tcacctcggt gtttcgcgac tacggctacc ggcgactgcg
cgccaaggcc cggctgaaat ttctgatcaa agactggggc atagcgaagt
tccgcgaagt gctcgaaacc gagtacctca agcgtccgct gatcgacggt
ccggcccccg aaccggtcaa gcatccgatc gaccacgtcg gggtgcaacg
actcaagaac gggctcaacg ccgtcggagt cgcccccatc gccgggcggg
tatcgggcac catcctcacg gcggtcgccg acctgatggc gcgggccggt
tccgaccgga tccggttcac cccctaccag aagctggtca tcctcgacat
tccggacgcc ttgctcgacg acttgatcgc cggtctggac gcgctggggc
ttcagtcgcg cccgtcgcat tggcgccgga acttgatggc gtgcagcggg
attgagttct gcaagttgtc attcgccgaa acccgggttc gagcacagca
tttggtgccc gagctggaac gccggcttga ggacatcaac tcgcagctcg
acgtaccgat caccgtcaac atcaacggct gcccgaactc atgtgcgcga
gttcaaatcg ccgacatcgg attcaaggga cagatgatcg acgacggaca
cggcggctcc gtcgaaggct tccaggtgca tctgggcgga cacctcggcc
tggatgccgg attcggccgc aaactgcgcc agcacaaggt caccagtgac
gaactcggcg actacatcga ccgggtggtg cgcaacttcg tcaaacaccg
cagcgaaggt gaacgcttcg cgcagtgggt catccgggcc gaggaggacg
acctgcgatg agcggccgcc taggactact agtctgcagt ttttcctt
Mycobacterium smegmatis
This reference also contains the cloning of sirA from T. smegmatis. We used the primers below taken from Pinto et al, blasted against the T. smegmatis genome and extracted the sirA sequence from genbank as above.
Primers:
smegsirA F TACAGCTGATGCTCGAAGACGAGTACTTCAT
smegsirA R CCCAAGCTTTCACGTTGCCTACCTCAAATCCGCTTCGTC
tacagctgat gctcgaagac gagtacttca tgctgcgcgt gcgctgcgat
ggtggcgcgc tgaccactgc agcgctgcgc acgctcggcg gcatctcgac
cgagttcgcg cgcgacaccg ccgacatctc cgaccgcgag aacgtccagt
accactggat ccaggtcgag aacatgcccg agatctggaa gcgcctcgac
gccgtcggcc tgcagaccac cgaggcgtgc ggcgactgcc cgcgtgtggt
cctcggctcg ccgctggccg gtgagtccct cgacgaggtg atcgacggga
cccccgcgat cgacgagatc gtgcgccgct acatcggcaa gcccgagtac
tcgaacctgc cgcgcaagtt caagaccgcg atctcggggc ttcaggacgt
ggtccacgag gtcaacgacg tcgcgttcat cggcgtcaac caccccgagc
acggcccggg cttcgacctg tgggtcggtg gcggcctgtc gaccaacccg
atgctggccc agcgcgtcgg ggtgtgggtg ccgctcgacg aggtgcccga
cgtctgggag ggcgtcgtca gcatcttccg cgactacggt taccggcgtc
tgcggtcgaa ggcgcggctg aagttcctga tcaaggactg gggcgtcgaa
aagttcaggg aagtgctgga aaccgagtac ctcaagcgcc ccctgatcga
cggcccggca cccgaaccgg tgacccgccc catcgaccac gtcggtgtgc
agaagctcaa gaacggcctc aacgccgtgg gcgtcgcccc gatcgcgggt
cgcgtctcgg gcacgatcct gaccaaggtg gccgatctcg ccgaggccgc
cgggtccgac cggatccgct tcacgccgta ccagaagctg atcatcctcg
acgtgcccga cgacaagatc gacgaactgc gcgctggcct cgacgcgctc
ggactgccgt cgacgccgtc gcactggcgc cgcaacctca tggcgtgcac
gggtatcgag ttctgcaagc tgagcttcgc cgagacccgc aagcgtgccc
aggtgctggt tcccgagctg gagaaacggc tcgacgacat caacgcccag
ctcgacgtgc ccatcacggt caacatcaac ggctgcccca actcgtgcgc
ccgtatccag gtcgccgaca tcgggttcaa gggccagatg gtcgacgatg
gcaacggccc cgaggagggt ttccaggtgc atctgggcgg cagcctgggc
ctggacagcg ggttcggccg caagctgcgc cagcacaagg tgctctcgtc
cgagctcggc gactacatcg agcgcgtcgt gcgcaacttc gtgaaacaac
gcgaggacgg cgagcgtttc gcccagtggg ccgtgcgggc cgacgaagcg
gatttgaggt aggcaacgtg aaagcttggg
As above, the sequence was imported into geneious, the biobrick restriction sites were manually removed from the sequence and restriction sites were added to the 5’ and 3’ ends in the same fashion as TB sirA. This resulted in the following sequence for synthesis:
tacagaattc tagaccatgg gcctcgaaga cgagtacttc atgctgcgcg
tgcgctgcga tggtggcgcg ctgaccacta cagcgctgcg cacgctcggc
ggcatctcga ccgagttcgc gcgcgacacc gccgacatct ccgaccgcga
gaacgtccag taccactgga tccaggtcga gaacatgccc gagatctgga
agcgcctcga cgccgtcggc ctacagacca ccgaggcgtg cggcgactgc
ccgcgtgtgg tcctcggctc gccgctggcc ggtgagtccc tcgacgaggt
gatcgacggg acccccgcga tcgacgagat cgtgcgccgc tacatcggca
agcccgagta ctcgaacctg ccgcgcaagt tcaagaccgc gatctcgggg
cttcaggacg tggtccacga ggtcaacgac gtcgcgttca tcggcgtcaa
ccaccccgag cacggcccgg gcttcgacct gtgggtcggt ggcggcctgt
cgaccaaccc gatgctggcc cagcgcgtcg gggtgtgggt gccgctcgac
gaggtgcccg acgtctggga gggcgtcgtc agcatcttcc gcgactacgg
ttaccggcgt ctgcggtcga aggcgcggct gaagttcctg atcaaggact
ggggcgtcga aaagttcagg gaagtgctgg aaaccgagta cctcaagcgc
cccctgatcg acggcccggc acccgaaccg gtgacccgcc ccatcgacca
cgtcggtgtg cagaagctca agaacggcct caacgccgtg ggcgtcgccc
cgatcgcggg tcgcgtctcg ggcacgatcc tgaccaaggt ggccgatctc
gccgaggccg ccgggtccga ccggatccgc ttcacgccgt accagaagct
gatcatcctc gacgtgcccg acgacaagat cgacgaactg cgcgctggcc
tcgacgcgct cggactgccg tcgacgccgt cgcactggcg ccgcaacctc
atggcgtgca cgggtatcga gttctgcaag ctgagcttcg ccgagacccg
caagcgtgcc caggtgctgg ttcccgagct ggagaaacgg ctcgacgaca
tcaacgccca gctcgacgtg cccatcacgg tcaacatcaa cggctgcccc
aactcgtgcg cccgtatcca ggtcgccgac atcgggttca agggccagat
ggtcgacgat ggcaacggcc ccgaggaggg tttccaggtg catctgggcg
gcagcctggg cctggacagc gggttcggcc gcaagctgcg ccagcacaag
gtgctctcgt ccgagctcgg cgactacatc gagcgcgtcg tgcgcaactt
cgtgaaacaa cgcgaggacg gcgagcgttt cgcccagtgg gccgtgcggg
ccgacgaagc ggatttgagg taggcaacgt gaaagcctag gtactagtct
gcagtggg